Tutorials
BSP:A1SN34 (Denmark)  
Ascendis Pharma A/S logo

Ascendis Pharma A/S

R$ 30.93 (0%) Aug 9
P/E:
At Loss
P/B:
7.45
Market Cap:
R$ 1.73B ($ 336.76M)
Enterprise V:
R$ 23.95B ($ 4.67B)
Volume:
-
Avg Vol (2M):
199.00
Also Trade In:
Volume:
-
Market Cap R$:
1.73B
Market Cap $:
336.76M
PE Ratio:
At Loss
Avg Vol (2-Month):
199.00
Enterprise Value R$:
23.95B
Enterprise Value $:
4.67B
PB Ratio:
7.45
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Ascendis Pharma A/S
NAICS : 325411
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Description
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Name Current Vs Industry Vs History
Cash-To-Debt 2.07
Equity-to-Asset 0.49
Debt-to-Equity 0.7
Debt-to-EBITDA -1.1
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.1
Distress
Grey
Safe
Beneish M-Score -1.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.78
9-Day RSI 31.8
14-Day RSI 42.45
6-1 Month Momentum % -22.93
12-1 Month Momentum % -23.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.76
Quick Ratio 10.79
Cash Ratio 10.26
Days Inventory 6557.34
Days Sales Outstanding 47.07
Days Payable 5505.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.6

Financials (Next Earnings Date:2022-08-10)

BSP:A1SN34's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 81.823
EPS (TTM) (R$) -48.329
Beta 0
Volatility % 52.44
14-Day RSI 42.45
14-Day ATR (R$) 0.172906
20-Day SMA (R$) 31.3905
12-1 Month Momentum % -23.98
52-Week Range (R$) 22.44 - 62.6
Shares Outstanding (Mil) 55.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ascendis Pharma A/S Filings

Document Form Filing Date
No Filing Data